Transplantation and cellular therapy
Cytokine-induced Killer Cell Therapy as a Post-remission Strategy in High-risk Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation: A Prospective Investigator-Initiated Clinical Study.
Gi-June Min, Nayoun Kim, Keon-Il Im, Junseok Lee, Taeyeon Kim, Dong Jip Kim, Seok-Goo Cho
Published: 202610.1016/j.jtct.2026.01.001
Abstract
BACKGROUND: In high-risk non-Hodgkin lymphoma (NHL) with complete remission (CR), intensive chemotherapy and autologous stem cell transplantation (ASCT) provide additional benefits. However, despite the benefits, minimal residual disease-induced rela…
Preview only. Read the full abstract at the source